Literature DB >> 5787318

Long-term effects of clofibrate (Atromid-S) on serum lipids in man.

D B Hunninghake, D R Tucker, D L Azarnoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5787318     DOI： 10.1161/01.cir.39.5.675

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  Clofibrate disposition in renal failure and acute and chronic liver disease.

Authors:  R Gugler; J W Kürten; C J Jensen; U Klehr; J Hartlapp
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

2.  Effects of ethyl p-chlorophenoxyisobutyrate on biliary secretion of bile acids, cholesterol and phosphatidyl choline.

Authors:  M G Horning; R M Hebert; R J Roth; D L Davis; E C Horning; E P Fischer; G L Jordan
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

3.  Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.

Authors:  A Eisalo; V Manninen
Journal:  Proc R Soc Med       Date:  1976

4.  [Fat and renal failure--therapeutic aspects].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-08

5.  Ten years clinical experience with partial ileal bypass in management of the hyperlipidemias.

Authors:  H Buchwald; R B Moore; R L Varco
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

6.  Bioavailability of p-chlorophenoxyisobutyric acid (clofibrinic acid) after repeated doses of its calcium salt to humans.

Authors:  T Taylor; L F Chasseaud; A Darragh; D A O'Kelly
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.